Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Savara Announces Appointment of Pharmaceutical Veteran to Board of Directors

Abstract:
Richard Hawkins, Founder and Former CEO of PPD Pharmaco, Joins Board

Savara Announces Appointment of Pharmaceutical Veteran to Board of Directors

Austin, TX | Posted on November 8th, 2010

Savara Inc., an inhalation product development company, today announced that it has appointed Richard Hawkins to its Board of Directors.

In 1983 Mr. Hawkins founded Pharmaco and as Chairman, President and CEO he guided the growth of that organization to over 700 employees. It eventually became PPD Pharmaco, one of the largest clinical contract research organizations in the world. Since Pharmaco, he has served in various capacities in numerous startup companies, including Sensus Drug Development Corporation, which was sold to Pfizer; Covance Biotechnology Services, which was sold to Akzo Nobel Inc. in early 2001; and LoopOne, Inc., which was sold to Neopost in May 2001.

"We are honored to have someone with Mr. Hawkins' track record join the Board of Directors," said Rob Neville, CEO of Savara. "We now have the board and executive team in place to move our lead product into the clinic."

Mr. Hawkins currently serves on the Board of Directors for SciClone Pharmaceuticals Inc. and on the Board for Cytori Therapeutics Inc. Recently he co-founded and acted as CEO, President and Chairman of Austin-based LabNow. In 2006 he was named one the top 10 Life Sciences CEO's in Texas by the Texas Healthcare & Bioscience Institute.

"I have been following Savara for some time and am very impressed with their technologies and progress," said Mr. Hawkins. "It is clear that this team is passionate, focused and knows how to execute."

Mr. Hawkins is a member of the National Ernest and Young Entrepreneur of the Year Hall of Fame and received the Ernest and Young 1991 Service Industry Award - Austin Region.

####

About Savara Inc.
Savara Inc. is an inhalation drug development company developing next-generation respiratory therapeutics utilizing its proprietary NanoCluster dry-powder formulation technology. Savara's NanoCluster technology is currently available for evaluation and licensing.

For more information, please click here

Contacts:
Partners:
Taneli Jouhikainen
(888) 302-4876


Investors:
Rob Neville
(888) 302-4876

Copyright © PrNewswire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Three-dimensional graphene: Experiment at BESSY II shows that optical properties are tuneable May 24th, 2017

Leti to Demo 1st Wireless UNB Transceiver for ‘Massive Internet of Things’ at RFIC 2017 and IMS 2017: Leti Will also Present Three Papers & Two Workshops on 5G Communications IC Design, from RF to mm-Wave, During IMS 2017 and RFIC 2017 in Hawaii May 24th, 2017

GLOBALFOUNDRIES and Chengdu Partner to Expand FD-SOI Ecosystem in China: More than $100M investment to establish a center of excellence for FDXTM FD-SOI design May 23rd, 2017

Zap! Graphene is bad news for bacteria: Rice, Ben-Gurion universities show laser-induced graphene kills bacteria, resists biofouling May 22nd, 2017

Announcements

Three-dimensional graphene: Experiment at BESSY II shows that optical properties are tuneable May 24th, 2017

Leti to Demo 1st Wireless UNB Transceiver for ‘Massive Internet of Things’ at RFIC 2017 and IMS 2017: Leti Will also Present Three Papers & Two Workshops on 5G Communications IC Design, from RF to mm-Wave, During IMS 2017 and RFIC 2017 in Hawaii May 24th, 2017

GLOBALFOUNDRIES and Chengdu Partner to Expand FD-SOI Ecosystem in China: More than $100M investment to establish a center of excellence for FDXTM FD-SOI design May 23rd, 2017

Zap! Graphene is bad news for bacteria: Rice, Ben-Gurion universities show laser-induced graphene kills bacteria, resists biofouling May 22nd, 2017

Appointments/Promotions/New hires/Resignations/Deaths

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Francis Alexander Named Deputy Director of Brookhaven Lab's Computational Science Initiative February 16th, 2017

Nanobiotix appoints senior executive from pharmaceutical industry, as Chief Operating Officer: Oncology industry veteran to oversee operations and product commercialization February 8th, 2017

Dr Barbara Armbruster promoted to Worldwide Sales and Marketing Director for XEI Scientific September 27th, 2016

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project